(1)
Sharma, S.; Chaturvedi, A.; Dave, N.; Shah, A. Long-Term Efficacy and Safety of RazumabTM (biosimilar Ranibizumab) in Indian Patients With Retinal Diseases: Results from Retrospective REAR RD-2 Study. Int J Clin Trials 2022, 9, 255-262.